Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Flavisolibacter

ABSTRACT: Flavisolibacter sp. overview

PROVIDER: PRJNA514396 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	JACJGO01.dat.gz	Other
	JACJGO01.fasta.gz	Fasta.gz
	JACJGO01.master.dat	Other
	RBCI01.dat.gz	Other

Items per page:

1 - 5 of 7

Similar Datasets

Flavisolibacter ginsenosidimutans

Project description:Flavisolibacter ginsenosidimutans Genome sequencing

| PRJNA558431 | ENA

Flavisolibacter ginsengiterrae DSM 18136

Project description:Flavisolibacter ginsengiterrae DSM 18136 Genome sequencing

| PRJNA234986 | ENA

Flavisolibacter tropicus strain:LCS9

Project description:Flavisolibacter tropicus strain:LCS9 Genome sequencing

| PRJNA272876 | ENA

Flavisolibacter ginsengisoli DSM 18119

Project description:Flavisolibacter ginsengisoli DSM 18119 Genome sequencing

| PRJNA245675 | ENA

Flavisolibacter nicotianae strain:X7X

Project description:Flavisolibacter nicotianae strain:X7X Genome sequencing and assembly

| PRJNA493060 | ENA

Flavisolibacter longurius strain:BT320

Project description:Flavisolibacter longurius strain:BT320 Genome sequencing and assembly

| PRJNA635755 | ENA

Flavisolibacter longurius strain:BT320

Project description:Flavisolibacter longurius strain:BT320 Genome sequencing and assembly

| PRJNA635758 | ENA

Project description:Flavisolibacter ginsengisoli DSM 18119

| PRJEB18174 | ENA

Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutations [Methylation]

Project description:Background: Ependymomas encompass multiple, clinically relevant tumor types based on localization and molecular profiles. Although tumors of the methylation class “spinal ependymoma” (SP-EPN) represent the most common intramedullary neoplasms in children and adults, their developmental origin is ill-defined, molecular data are scarce, and the potential heterogeneity within SP-EPN remains unexplored. The only known recurrent genetic events in SP-EPN are loss of chromosome 22q and NF2 mutations, but neither types and frequency of these alterations nor their clinical meaning have been described in a large, epigenetically defined series. Methods: We mapped SP-EPN transcriptomes (n=76) to developmental atlases of the developing and adult spinal cord to uncover potential developmental origins of these tumors. In addition, transcriptomic, epigenetic (n=234), genetic (n=140), and clinical analyses (n=115) were integrated for a detailed overview on this entity. Results: Integration of transcriptomic ependymoma data with single-cell atlases of the spinal cord identified mature adult ependymal cells to display highest similarities to SP-EPN. Unsupervised hierarchical clustering of tumor data together with integrated analysis of methylation profiles identified two molecular SP-EPN subtypes. Subtype 1 predominantly contained NF2 wild type sequences with regular NF2 expression but revealed more extensive copy number alterations. Subtype 2 harbored previously known germline or sporadic NF2 mutations and was NF2-deficient in most cases, more often showed multilocular disease, and demonstrated a significantly reduced progression-free survival. Conclusion: Based on integrated molecular profiling of a large tumor series we identify two distinct SP-EPN subtypes with important implications for genetic counseling, patient surveillance, and drug development priorities.

2024-01-26 | GSE242991 | GEO